Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Cell morphology shifts toward more cuboidal shapes, indicating increased stemness and restored proliferative potential
Published 2019 Aug 31
Digestive issues, including nausea, vomiting, and abdominal discomfort, may arise
In the realm of cell-based therapies and antibodydrug conjugates (ADCs), CT041, a CLDN18.2-targeted CAR-T product, is being studied in gastrointestinal cancers (NCT04404595), while enfortumab vedotin, targeting Nectin-4, is under investigation for metastatic castration-resistant prostate cancer (NCT04754191)
Although most of the knowledge we have regarding its efficacy relates to repair and recovery, BPC is short for Body Protection Compound 157
US$ 29.50
US$ 20.50
US$ 23.71
US$ 20.03
US$ 23.23
US$ 20.80
US$ 22.18
US$ 27.20
